Thank you, Eva, and thank you all for joining us this morning. Before turning to our fourth quarter results, I would like to ...
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...
Chemical biomarkers are measurable molecular signatures (host immune markers, pathogen metabolites, volatile organic ...
UT Southwestern Medical Center researchers have identified two lipids that work together with a quintessential protein known ...
Apellis Pharmaceuticals (NASDAQ:APLS) used its fourth-quarter and full-year 2025 earnings call to highlight what management ...
Human MAP1LC3B (LC3B) binds proteins involved in autophagy and other cellular processes using a degenerate four-residue short linear motif known as the LC3-interacting region (LIR). Biochemical and ...